Expression of CD226 is upregulated on Tr1 cells from neuromyelitis optica spectrum disorder patients

BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a central and acute demyelinating disease of the central nervous system with unusual clinical course. The development of novel biomarkers for NMOSD is critical for implementing effective clinical treatment. CD226 is known to be expressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ping, Wu, Mingmei, Wang, Ning, Xia, Feng, Du, Fang, Liu, Zhirong, Wang, Jinchun, Jin, Jingyi, Jin, Boquan, Zhao, Gang, Chen, Lihua, Yi, Jing, Fang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226801/
https://www.ncbi.nlm.nih.gov/pubmed/35587519
http://dx.doi.org/10.1002/brb3.2623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226801/
https://www.ncbi.nlm.nih.gov/pubmed/35587519
http://dx.doi.org/10.1002/brb3.2623

Ejemplares similares